Fortress Biotech (FBIO) Selling, General & Administrative (2010 - 2026)
Powered by 
Analysis
Fortress Biotech (FBIO) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | -417.00 Mn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 216.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 110.21 Mn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 593.21 Mn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 161.89 Mn |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 247.47 Mn |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | 20.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.81 Mn |
| Dec 31, 2025 | 14.73 Mn |
| Sep 30, 2025 | 17.42 Mn |
| Jun 30, 2025 | 38.76 Mn |
| Mar 31, 2025 | 25.66 Mn |
| Dec 31, 2024 | 26.86 Mn |
| Sep 30, 2024 | 21.99 Mn |
| Jun 30, 2024 | 20.82 Mn |
| Mar 31, 2024 | 17.94 Mn |
| Dec 31, 2023 | 19.47 Mn |
| Sep 30, 2023 | 21.73 Mn |
| Jun 30, 2023 | 24.44 Mn |
| Mar 31, 2023 | 25.34 Mn |
| Dec 31, 2022 | 28.20 Mn |
| Sep 30, 2022 | 30.14 Mn |
| Jun 30, 2022 | 29.05 Mn |
| Mar 31, 2022 | 26.27 Mn |
| Dec 31, 2021 | 27.70 Mn |
| Sep 30, 2021 | 22.22 Mn |
| Jun 30, 2021 | 19.38 Mn |